Product Details

Nexgard Spectra 9 mg / 2 mg Chewable Tablets for Dogs 1.35–3.5 kg

• MA holder: Boehringer Ingelheim Vetmedica GmbH
• VM number: 61700/5032
• Territory: Great Britain
• Associated documents:
  • View Summary of Product Characteristics
  • View Product Literature (labelling and package leaflet text)
  • View Post Authorisation Assessment
• Authorised from: 14/01/2015
• Authorisation route: National
• Active substances:
  • Afoxolaner
  • Milbemycin Oxime (A3 and A4)
• Target species:
  • Dogs
• Distribution category: POM-V
• Distributors:
  • Boehringer Ingelheim Vetmedica GmbH